Technology | July 30, 2012

Emerge Nuclear Software Can Diagnose Appropriate Use

Software can help determine when perfusion imaging is needed, even without obvious symptoms

July 30, 2012 — Emerge Clinical Solutions, a creator of clinical decision support software, announced nuclear myocardial perfusion imaging (MPI) appropriateness update 3.1 that allows for diagnosis of both symptomatic and asymptomatic conditions.

In medicine, patients are simpler to diagnose when they show clear symptoms or signs of disease or injury. However, often an illness is asymptomatic, which means it is present but does not demonstrate obvious symptoms. Asymptomatic patients can be a challenge since asymptomatic illnesses are particularly difficult to discover and diagnose, especially in early stages.

Emerge’s real-time clinical decision solution helps doctors increase diagnosis efficiency and accuracy by filtering comprehensive patient data and history through the company’s rules engine and patented algorithms. The software has been proven to increase identification of certain cardiac diseases by as much as 300 percent. The Emerge rules engine performs more than 8,000 calculations in seconds to help doctors elect the most appropriate testing and procedures and choose a care path.

“Asymptomatic conditions are difficult to uncover, but they are no less threatening to a patient’s health. Emerge’s agnostic software can process data exponentially faster than any human brain, so it helps doctors find the right solution quickly. Time is of the essence when it comes to cardiology, and we help doctors decide the best care path without losing time on unnecessary testing,” said Emerge CEO Scott Finfer.

Cardiologists are often overwhelmed with the volume of information and data to consider when evaluating patients. Emerge’s software simplifies the decision process and merges seamlessly with any electronic medical record (EMR), integrating in real-time. Its algorithms utilize appropriate use criteria and guidelines from the American College of Cardiology (ACC), American Health Association (AHA) and Heart Rhythm Society (HRS). The software exceeds stage 1 meaningful use requirements, as well as the proposed requirements of stages 2 and 3.

For more information: www.emergecds.com

Related Content

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

Feature | Clinical Decision Support | January 18, 2018
January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader
Videos | Artificial Intelligence | January 18, 2018
ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence advances at the Radiological Soci
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
Sponsored Content | Videos | Enterprise Imaging | January 17, 2018
Mitchell Goldburgh, global solutions manager for enterprise imaging and analytics manager for NTT Data Services, form
Sponsored Content | Videos | Enterprise Imaging | January 16, 2018
Built on an over 25-year pioneering legacy in the advanced visualization industry, Vital continues to expand on three
RSNA 2017 Celebrates Innovation in Radiology
News | Imaging | January 15, 2018
January 15, 2018 — The Radiological Society of North America’s...
News | Clinical Decision Support | January 12, 2018
January 12, 2018 — GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop an
The artificial intelligence (AI) smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices.

The AI smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices. The size of the bleed volume indicates the urgency and type of treatment required.

Feature | Artificial Intelligence | January 10, 2018 | Greg Freiherr
Exhibitors at the 2017 Radiological Society of North American (RSNA) meeting rode the...
Videos | Enterprise Imaging | January 09, 2018
Konica Minolta President of Healthcare IT Steve Deaton details new features in the Exa Platform designed to improve c
Toshiba Medical Systems Changes Name to Canon Medical Systems Corp.
News | Business | January 08, 2018
Canon Inc. and Canon Medical Systems Corp. announced the official corporate name (trade name) change of Canon Group...
Overlay Init